Genetic polymorphisms and the fate of the transplanted organ

Transplantation Reviews

Volumn 22, Issue 2, 2008, Pages 131-140

  Krüger, Bernd ^a,b   Schröppel, Bernd ^a   Murphy, Barbara T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD31 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; COMPLEMENT COMPONENT C3; CYCLOSPORIN; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; L SELECTIN; MANNOSE BINDING LECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; PADGEM PROTEIN; PROTHROMBIN; RANTES; RAPAMYCIN; TACROLIMUS; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADAPTIVE IMMUNITY; ARTICLE; BLOOD CLOTTING; CELL MIGRATION; DRUG METABOLISM; FIBROSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; OUTCOMES RESEARCH; PHARMACOGENETICS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

CELL ADHESION MOLECULES; CELL MOVEMENT; CHEMOKINES; CYTOKINES; GENETIC MARKERS; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; KIDNEY TRANSPLANTATION; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 40649092068     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2007.12.002     Document Type: Article

References (120)

1. H.U. Meier-Kriesche J.D. Schold T.R. Srinivas B. Kaplan Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era Am J Transplant 4 2004 378 383
2. J.R. Chapman P.J. O'Connell B.J. Nankivell Chronic renal allograft dysfunction J Am Soc Nephrol 16 2005 3015 3026
3. A.J. Matas A. Humar K.J. Gillingham Five preventable causes of kidney graft loss in the 1990s: a single-center analysis Kidney Int 62 2002 704 714
4. I.F. Charo R.M. Ransohoff The many roles of chemokines and chemokine receptors in inflammation N Engl J Med 354 2006 610 621
5. G. Bouma J.B. Crusius M. Oudkerk Pool Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease Scand J Immunol 43 1996 456 463
6. A.G. Wilson J.A. Symons T.L. McDowell H.O. McDevitt G.W. Duff Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Natl Acad Sci U S A 94 1997 3195 3199
7. A.B. Hahn J.C. Kasten-Jolly D.M. Constantino TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome Transplantation 72 2001 660 665
8. R. Pelletier V. Pravica C. Perrey Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation Transplantation 70 2000 674 680
9. F. Poli L. Boschiero F. Giannoni Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation Cytokine 12 2000 1778 1783
10. D. Sankaran A. Asderakis S. Ashraf Cytokine gene polymorphisms predict acute graft rejection following renal transplantation Kidney Int 56 1999 281 288
11. N.S. Alakulppi L.E. Kyllonen V.T. Jantti Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation Transplantation 78 2004 1422 1428
12. H. Fernandes B. Koneru N. Fernandes Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients Transplantation 73 2002 1886 1891
13. A. Hutchings L. Guay-Woodford J.M. Thomas Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients Pediatr Transplant 6 2002 69 77
14. S.E. Marshall A.J. McLaren N.A. Haldar M. Bunce P.J. Morris K.I. Welsh The impact of recipient cytokine genotype on acute rejection after renal transplantation Transplantation 70 2000 1485 1491
15. M. Müller-Steinhardt L. Fricke B. Muller B. Ebel H. Kirchner C. Hartel Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572 and -174 on long-term kidney allograft survival Am J Transplant 4 2004 402 406
16. M. Müller-Steinhardt C. Hartel B. Muller H. Kirchner L. Fricke The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival Kidney Int 62 2002 1824 1827
17. S. Dmitrienko D.I. Hoar R. Balshaw P.A. Keown Immune response gene polymorphisms in renal transplant recipients Transplantation 80 2005 1773 1782
18. L.G. Wramner J. Norrby M. Hahn-Zoric Impaired kidney graft survival is associated with the TNF-alpha genotype Transplantation 78 2004 117 121
19. D. Turner S.C. Grant N. Yonan Cytokine gene polymorphism and heart transplant rejection Transplantation 64 1997 776 779
20. K.W. Moore R. de Waal Malefyt R.L. Coffman A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765
21. C.F. Terry V. Loukaci F.R. Green Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation J Biol Chem 275 2000 18138 18144
22. D. Fishman G. Faulds R. Jeffery The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1998 1369 1376
23. C.G. Densem M. Ray I.V. Hutchinson N. Yonan N.H. Brooks Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy? J Heart Lung Transplant 24 2005 559 565
24. V.M. Montori A. Basu P.J. Erwin J.A. Velosa S.E. Gabriel Y.C. Kudva Posttransplantation diabetes: a systematic review of the literature Diabetes Care 25 2002 583 592
25. J. Bamoulid C. Courivaud M. Deschamps IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation J Am Soc Nephrol 17 2006 2333 2340
26. M. Fischereder B. Luckow B. Hocher CC chemokine receptor 5 and renal-transplant survival Lancet 357 2001 1758 1761
27. B. Krüger B. Schröppel R. Ashkan A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation J Am Soc Nephrol 13 2002 2585 2589
28. B. Schröppel M. Fischereder M. Lin Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients J Clin Immunol 22 2002 381 385
29. B. Krüger C.A. Böger A. Obed RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection Clin Transplant 21 2007 385 390
30. S. Hoffmann J. Park L.M. Jacobson Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy Kidney Int 66 2004 1686 1693
31. A.J. McLaren S.E. Marshall N.A. Haldar Adhesion molecule polymorphisms in chronic renal allograft failure Kidney Int 55 1999 1977 1982
32. S. Borozdenkova J. Smith S. Marshall M. Yacoub M. Rose Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation Hum Immunol 62 2001 247 255
33. J.M. Yabu F. Vincenti Novel immunosuppression: small molecules and biologics Semin Nephrol 27 2007 479 486
34. S.C. Gough L.S. Walker D.M. Sansom CTLA4 gene polymorphism and autoimmunity Immunol Rev 204 2005 102 115
35. D.S. Graham A.K. Wong N.J. McHugh J.C. Whittaker T.J. Vyse Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study Hum Mol Genet 15 2006 3195 3205
36. A. Blomhoff B.A. Lie A.G. Myhre Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease J Clin Endocrinol Metab 89 2004 3474 3476
37. Y.H. Lee J.D. Ji J. Sohn G.G. Song Polymorphisms of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter -670 in spondyloarthropathies Clin Rheumatol 20 2001 420 422
38. B.A. Marder B. Schröppel M. Lin The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation Am J Transplant 3 2003 424 431
39. E. Slavcheva E. Albanis Q. Jiao Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection Transplantation 72 2001 935 940
40. Y. Ban T.F. Davies D.A. Greenberg Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease Genes Immun 4 2003 586 593
41. B. Marder B. Schröppel B. Murphy Genetic variability and transplantation Curr Opin Urol 13 2003 81 89
42. P. de Reuver V. Pravica W. Hop Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation Am J Transplant 3 2003 1587 1594
43. O. Tapirdamaz V. Pravica H.J. Metselaar Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation Gut 55 2006 863 868
44. G. Trinchieri A. Sher Cooperation of Toll-like receptor signals in innate immune defence Nat Rev Immunol 7 2007 179 190
45. D. Ducloux M. Deschamps M. Yannaraki Relevance of Toll-like receptor-4 polymorphisms in renal transplantation Kidney Int 67 2005 2454 2461
46. S.M. Palmer L.H. Burch S. Mir Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation Clin Transplant 20 2006 30 36
47. C.F. Andrade T.K. Waddell S. Keshavjee M. Liu Innate immunity and organ transplantation: the potential role of toll-like receptors Am J Transplant 5 2005 969 975
48. D.R. Goldstein Toll like receptors and acute allograft rejection Transpl Immunol 17 2006 11 15
49. M.P. Davey T.M. Martin S.R. Planck J. Lee D. Zamora J.T. Rosenbaum Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide Microvasc Res 71 2006 103 107
50. J.P. Hugot M. Chamaillard H. Zouali Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
51. J. Hampe J. Grebe S. Nikolaus Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study Lancet 359 2002 1661 1665
52. B. Krüger C.A. Böger B. Schröppel Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation Transpl Int 2007
53. G.K. Hansson P. Libby U. Schonbeck Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
54. W. Zhou C.A. Farrar K. Abe Predominant role for C5b-9 in renal ischemia/reperfusion injury J Clin Invest 105 2000 1363 1371
55. P.S. Heeger P.N. Lalli F. Lin Decay-accelerating factor modulates induction of T cell immunity J Exp Med 201 2005 1523 1530
56. K.M. Brown E. Kondeatis R.W. Vaughan Influence of donor C3 allotype on late renal-transplantation outcome N Engl J Med 354 2006 2014 2023
57. M.W. Turner The role of mannose-binding lectin in health and disease Mol Immunol 40 2003 423 429
58. S.P. Berger A. Roos M.J. Mallat Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation J Am Soc Nephrol 18 2007 2416 2422
59. S.P. Berger A. Roos M.J. Mallat T. Fujita J.W. de Fijter M.R. Daha Association between mannose-binding lectin levels and graft survival in kidney transplantation Am J Transplant 5 2005 1361 1366
60. J.A. Castillo-Lugo P. Vergne-Marini Hypertension in kidney transplantation Semin Nephrol 25 2005 252 260
61. K. Lindpaintner M.A. Pfeffer R. Kreutz A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease N Engl J Med 332 1995 706 711
62. H. Schunkert H.W. Hense S.R. Holmer Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy N Engl J Med 330 1994 1634 1638
63. D. Yong W.Q. Qing L. Hua Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: a meta-analysis Am J Nephrol 26 2006 511 518
64. A. Akcay S. Sezer F.N. Ozdemir Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction Transplantation 78 2004 892 898
65. S. Barocci F. Ginevri U. Valente F. Torre R. Gusmano A. Nocera Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis Transplantation 67 1999 534 538
66. D.A. Cunningham S.J. Crisp M. Barbir F. Lazem M.J. Dunn M.H. Yacoub Donor ACE gene polymorphism: a genetic risk factor for accelerated coronary sclerosis following cardiac transplantation Eur Heart J 19 1998 319 325
67. K. Pethig B. Heublein A. Hoffmann J. Borlak T. Wahlers A. Haverich ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients J Heart Lung Transplant 19 2000 1175 1182
68. O. Viklicky J.A. Hubacek J. Pitha ACE gene polymorphism and long-term renal graft function Clin Biochem 34 2001 87 90
69. J. Beige S. Scherer A. Weber Angiotensin-converting enzyme genotype and renal allograft survival J Am Soc Nephrol 8 1997 1319 1323
70. J. Beige G. Offermann A. Distler A.M. Sharma Angiotensin-converting-enzyme insertion/deletion genotype and long-term renal allograft survival Nephrol Dial Transplant 13 1998 735 738
71. J. Nicod A. Richard F.J. Frey P. Ferrari Recipient RAS gene variants and renal allograft function Transplantation 73 2002 960 965
72. A. Yildiz H. Yazici N. Cine The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients Clin Transplant 16 2002 173 179
73. E. Brand N. Chatelain P. Mulatero Structural analysis and evaluation of the aldosterone synthase gene in hypertension Hypertension 32 1998 198 204
74. E. Davies C.D. Holloway M.C. Ingram Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2 Hypertension 33 1999 703 707
75. L. Gallon E. Akalin P. Lynch ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients Transplantation 81 2006 463 468
76. S. Heidenreich C. Dercken C. August H.G. Koch U. Nowak-Gottl High rate of acute rejections in renal allograft recipients with thrombophilic risk factors J Am Soc Nephrol 9 1998 1309 1313
77. R.P. Wüthrich Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis Curr Opin Nephrol Hypertens 10 2001 409 414
78. R.P. Wüthrich S. Cicvara-Muzar C. Booy F.E. Maly Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss Transplantation 72 2001 549 550
79. H. Ekberg P.J. Svensson M. Simanaitis B. Dahlback Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection Transplantation 69 2000 1577 1581
80. B. Hocher T. Slowinski I. Hauser Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients Thromb Haemost 87 2002 194 198
81. M. Meyer G. Laux S. Scherer T.H. Tran G. Opelz J. Mytilineos No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study Transplantation 83 2007 1055 1058
82. G. Hirshfield J.D. Collier K. Brown Donor factor V Leiden mutation and vascular thrombosis following liver transplantation Liver Transpl Surg 4 1998 58 61
83. M. Fischereder H. Schneeberger P. Lohse B.K. Krämer D. Schlöndorff W. Land Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene Am J Kidney Dis 38 2001 1061 1064
84. E. Salido B. Martin Y. Barrios The PlA2 polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection J Am Soc Nephrol 10 1999 2599 2605
85. R. Günesacar G. Opelz E. Erken VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome Hum Immunol 68 2007 599 602
86. M. Shahbazi A.A. Fryer V. Pravica Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection J Am Soc Nephrol 13 2002 260 264
87. P. Frosst H.J. Blom R. Milos A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1995 111 113
88. S.S. Kang P.W. Wong A. Susmano J. Sora M. Norusis N. Ruggie Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease Am J Hum Genet 48 1991 536 545
89. R. Clarke L. Daly K. Robinson Hyperhomocysteinemia: an independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
90. W.C. Winkelmayer R. Kramar G. Sunder-Plassmann M. Födinger Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients Kidney Int 68 2005 2857 2862
91. K. Kalantar-Zadeh J.D. Kopple M.H. Humphreys G. Block Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients Nephrol Dial Transplant 19 2004 1507 1519
92. C.R. Yates W. Zhang P. Song The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients J Clin Pharmacol 43 2003 555 564
93. M. Goto S. Masuda H. Saito C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than PGP in recipients of living-donor liver transplantation Pharmacogenetics 12 2002 451 457
94. D.A. Hesselink R.H. van Schaik I.P. van der Heiden Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus Clin Pharmacol Ther 74 2003 245 254
95. I.A. Macphee S. Fredericks T. Tai Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement Transplantation 74 2002 1486 1489
96. D. Anglicheau C. Verstuyft P. Laurent-Puig Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients J Am Soc Nephrol 14 2003 1889 1896
97. H. Zheng S. Webber A. Zeevi Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms Am J Transplant 3 2003 477 483
98. T. Kuzuya T. Kobayashi N. Moriyama Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients Transplantation 76 2003 865 868
99. I. Mai E. Stormer M. Goldammer MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients J Clin Pharmacol 43 2003 1101 1107
100. J.N. Roy A. Barama C. Poirier B. Vinet M. Roger Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients Pharmacogenet Genomics 16 2006 659 665
101. J.C. Kolars W.M. Awni R.M. Merion P.B. Watkins First-pass metabolism of cyclosporin by the gut Lancet 338 1991 1488 1490
102. P. Borst R. Evers M. Kool J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J Natl Cancer Inst 92 2000 1295 1302
103. T. Hashida S. Masuda S. Uemoto H. Saito K. Tanaka K. Inui Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation Clin Pharmacol Ther 69 2001 308 316
104. S. Choudhuri C.D. Klaassen Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters Int J Toxicol 25 2006 231 259
105. R.B. Kim B.F. Leake E.F. Choo Identification of functionally variant MDR1 alleles among European Americans and African Americans Clin Pharmacol Ther 70 2001 189 199
106. A. Westlind S. Malmebo I. Johansson Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43 Biochem Biophys Res Commun 281 2001 1349 1355
107. G.R. Wilkinson Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans J Pharmacokinet Biopharm 24 1996 475 490
108. P. Kuehl J. Zhang Y. Lin Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Nat Genet 27 2001 383 391
109. C.A. Felix A.H. Walker B.J. Lange Association of CYP3A4 genotype with treatment-related leukemia Proc Natl Acad Sci U S A 95 1998 13176 13181
110. B. Amirimani A.H. Walker B.L. Weber T.R. Rebbeck RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 J Natl Cancer Inst 91 1999 1588 1590
111. A.B. Spurdle B. Goodwin E. Hodgson The CYP3A4⁎1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer Pharmacogenetics 12 2002 355 366
112. T.R. Rebbeck J.M. Jaffe A.H. Walker A.J. Wein S.B. Malkowicz Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 J Natl Cancer Inst 90 1998 1225 1229
113. N. von Ahsen M. Richter C. Grupp B. Ringe M. Oellerich V.W. Armstrong No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients Clin Chem 47 2001 1048 1052
114. L.P. Rivory H. Qin S.J. Clarke Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance Eur J Clin Pharmacol 56 2000 395 398
115. B. Schröppel Genomic strategies in transplantation: the right drug for the right patient Current Pharmacogenomics 2 2004 175 184
116. A.M. Glazier J.H. Nadeau T.J. Aitman Finding genes that underlie complex traits Science 298 2002 2345 2349
117. H.M. Colhoun P.M. McKeigue G. Davey Smith Problems of reporting genetic associations with complex outcomes Lancet 361 2003 865 872
118. D.N. Cooper R.L. Nussbaum M. Krawczak Proposed guidelines for papers describing DNA polymorphism-disease associations Hum Genet 110 2002 207 208
119. S.C. Hoffmann E.M. Stanley E.D. Cox Ethnicity greatly influences cytokine gene polymorphism distribution Am J Transplant 2 2002 560 567
120. K. Solez R.B. Colvin L.C. Racusen Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’) Am J Transplant 7 2007 518 526